Actress And Tv Star Kyle Richards Diagnosed With A Type Of Chronic Dry Eye Disease

Tue, 09/23/2014 -- Science News Desk

TV personality, fashion entrepreneur and star of the "Real Housewives of Beverly Hills" Kyle Richards is partnering with Allergan, the makers of RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%, to raise awareness of Chronic Dry Eye. As many as 25 million people in the United States report suffering from dry eye.i Richards was diagnosed with a type of Chronic Dry Eye disease and was prescribed RESTASIS®, the first and only prescription medicine approved by the U.S. Food and Drug Administration that helps eyes’ natural ability to produce tears, which may be reduced by the inflammation caused by this medical condition. RESTASIS® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs. For the first time, Richards is sharing her experience to encourage others to talk to an eye doctor about this health concern and treatment options.

"A few years ago, during the filming of the ‘Housewives’ first season, I began to notice that my eyes were bothering me throughout the day. I started stashing artificial tears anywhere I might need them – in my purse and different areas of my house – using them several times a day for temporary relief," said Kyle. "The condition seemed to worsen over time, so I finally decided to see my eye doctor. I was surprised to find out that my eyes were not producing enough tears, and I had Chronic Dry Eye disease. My doctor prescribed RESTASIS® for me, and after using it daily for six months, I noticed I was making more of my own tears."

One type of Chronic Dry Eye disease occurs when eyes do not produce the right quantity of tears due to ocular inflammation.i Without enough tears, the film protecting the eye can break down, creating dry spots on the eye surface. Other causes of the disease include advanced age, contact lens wear, certain medications, eye diseases, other medical conditions or environmental factors.

"In my practice, I see many patients with Chronic Dry Eye disease who, like Kyle, have tried to find relief with artificial tears for several years before talking to an eye doctor," said Christopher E. Starr, M.D., Associate Professor of Ophthalmology, Director of Laser Vision Correction Surgery, and Director of the Fellowship Program in Cornea, Cataract & Refractive Surgery at Weill Cornell Medical Center, New York-Presbyterian Hospital. "Chronic Dry Eye is a disease, and once the condition is diagnosed, there are treatment options available. For those who are not making enough of their own tears due to the underlying inflammation, RESTASIS® is a prescription eye drop used daily, 12 hours apart, twice a day that has helped my patients produce more of their own tears."

To learn more about Kyle’s experience and to find an eye doctor in your area who treats Chronic Dry Eye disease, visit www.Restasis.com/KyleRichards.

RESTASIS® Important Information


Approved Use
RESTASIS® Ophthalmic Emulsion helps increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.

Allergan

 

Disclaimer: The information provided on SciGuru.com Science News is not intended to be a medical advice. The information on this website is also not intended to be used for diagnosis or treatment. The material provided on this site is of general informational purpose only. You may consult your physician or other qualified health provider for medical advice, diagnosis or treatment.  The inventions, discoveries, devices or products mentioned on SciGuru.com Science News may be in planning or experimental stages and may not have approval from regulatory agencies for human or animal use.